New Step by Step Map For lenmeldy
The FDA assessed the safety and effectiveness of atidarsagene autotemcel based upon knowledge from 37 small children who been given atidarsagene autotemcel in two one-arm, open up-label clinical trials and in an expanded access application.[7] Young children who acquired remedy with atidarsagene autotemcel were compared to untreated small children